✦ LIBER ✦

HCVAD plus Imatinib or Dasatinib for Lymphoid Blastic Phase of Chronic Myeloid Leukemia

✍ Scribed by Strati, Paolo; Kantarjian, Hagop; Thomas, Deborah; O'Brien, Susan; Jabbour, Elias; Quintas-Cardama, Alfonso; Borthakur, Gautam; Faderl, Stefan; Ravandi, Farhad; Cortes, Jorge

Book ID: 122266617
Publisher: Elsevier
Year: 2013
Tongue: English
Weight: 239 KB
Volume: 13
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2013.07.099

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HCVAD plus imatinib or dasatinib in lymp

HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemia

✍ Strati, Paolo; Kantarjian, Hagop; Thomas, Deborah; O'Brien, Susan; Konoplev, Ser 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB

First-line treatment for chronic myeloid

First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib

✍ Guoqing Wei; Shamudheen Rafiyath; Delong Liu 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 298 KB

Dasatinib: From Treatment of Imatinib-Re

Dasatinib: From Treatment of Imatinib-Resistant or -Intolerant Patients With Chronic Myeloid Leukemia to Treatment of Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

✍ Brian L. Abbott 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Medication adherence among adults prescr

Medication adherence among adults prescribed imatinib, dasatinib, or nilotinib for the treatment of chronic myeloid leukemia

✍ Anderson, K. R.; Chambers, C. R.; Lam, N.; Yau, P. S.; Cusano, F.; Savoie, M. L. 📂 Article 📅 2014 🏛 SAGE Publications 🌐 English ⚖ 186 KB

Efficacy and safety of dasatinib in imat

Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase

✍ Cortes, J; Kim, D-W; Raffoux, E; Martinelli, G; Ritchie, E; Roy, L; Coutre, S; C 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 148 KB

Nilotinib is active in chronic and accel

Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapy

✍ Giles, F J; Abruzzese, E; Rosti, G; Kim, D-W; Bhatia, R; Bosly, A; Goldberg, S; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 148 KB